Made with ❤️ by True Sparrow

Bringing you the latest funding data

Duetti

Last funding round

Raised
$90,000,000
Round
Unknown

Funding News (1)

Feb 15 2024PR Newswire

Startup details

Duetti

Duetti

Duetti is a music financing platform that democratizes the music business by enabling catalog monetization for independent artists. It provides data-driven prices for established tracks, allowing artists to sell individual tracks or parts thereof, while marketing those tracks using unique ROI-focused techniques.
duetti.co
New York, New York, United States
Established in 2022
11-50 People
Fintech, Asset Management

Founders

Lior Tibon

Lior Tibon

CEO and Co-Founder

New York City, New York, United States

Christopher Nolte

Christopher Nolte

COO & Co-Founder

Los Angeles, California, United States

Investment details

Total Funding
$120,000,000
Raised
$90,000,000
Round
Unknown
Investors
Nyca Partners
LEAD
Viola Ventures
Cohen Circle
Northleaf Capital Partners

Founder Stories

Dr. Sterghois Moschos, PulmoBioMed

Recent 5 from United States

Apr2024
1

Today

VulnCheck raised a $8.0M Seed led by Sorenson Capital
Utah-based VulnCheck provides cyberthreat intelligence platform for predicting attack avenues and prioritizing vulnerabilities.
VulnCheck

Founders

Anthony Bettini,

Jacob Baines

In News

SiliconANGLE
2

Today

Spintly raised a $2M Seed from Accel and 2 others
US-based Spintly Inc. offers cloud-based smart building solutions for physical access control.
Spintly

Founders

Rohin Parkar

In News

Outlook Business & Money
3

1 day ago

XFactor raised a $16M Series A led by Accel and 1 other
San Francisco-based Xfactor.io empowers revenue leaders with AI-powered go-to-market automation.
XFactor

Founders

Mike Carpenter

In News

Yahoo Finance
4

1 day ago

Superlogic raised $7.6M from Chainlink and 5 others
Superlogic is a Blockchain-powered loyalty solutions provider empowering brands with next-gen technology.
Superlogic

Founders

Lin Dai

In News

Forbes
The Crypto Times
Globe Echo
5

1 day ago

Metsera raised $290M led by ARCH Ventures
New York-based Metsera is a clinical-stage biopharmaceutical company focused on developing medicines for obesity and metabolic diseases.
Metsera

Founders

Daniel Hoey,

Gbola Amusa

In News

FinSMEs
ET Pharma
Devdiscourse
Spot a snag? Report it.
raised@truesparrow.com
Made with ❤️ by True Sparrow
© 2024 True Sparrow Systems Pvt. Ltd. All rights reserved.